Dr. Michael Peter Angarone, DO

Dr. Angarone practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Angarone's NPI, 1194806190, was assigned on October 17, 2006. Dr. Angarone graduated from Midwestern University, Chicago College of Osteopathic Med in 2002. Dr. Angarone holds Illinois license 036-114094.

Dr. Angarone's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Angarone's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. Dr. Angarone is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Angarone to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Angarone practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Angarone's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Angarone is licensed in Illinois.

CMS data shows 518 Medicare services from Dr. Angarone across 8 procedure codes in 2024, for 265 Medicare patients. Medicare paid $40,528 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 265 Medicare patients who saw Dr. Angarone in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 4.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Angarone's median patient age at 66, with 39% women.

In 2024, Dr. Angarone wrote 928 Medicare Part D claims for 125 patients. 57% of them were for generic drugs. CMS names the drug for 643 of them, across 22 drugs with 11 or more claims each, at $1,246,916 in total drug cost. In 2023, CMS named 637 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Angarone for performance year 2024, reported through an alternative payment model (APM). Dr. Angarone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Angarone as offering telehealth.

Dmand AI links 38 papers to Dr. Angarone, published from 2014 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Anti-Bacterial Agents, Immunocompromised Host and Organ Transplantation. Dr. Angarone has published most often in Transpl Infect Dis. Dr. Angarone's most frequent co-authors are Valentina Stosor, MD, Ignacio Alfonso Echenique, MD and Rebecca Nirmal Kumar, MD.

Dmand AI links Dr. Angarone to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Open Payments lists research payments to Dr. Angarone that name 1 trial.

CMS Open Payments shows 94 general payments to Dr. Angarone from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Allergan Inc. paid the most, $35,801. It also lists 3 research payments totaling $4,450 from 2020 to 2025, naming 1 clinical trial.

Dr. Angarone graduated from Midwestern University, Chicago College of Osteopathic Med in 2002.